
HIVE Blockchain Technologies Ltd. (CVE:HIV – Free Report) – Equities research analysts at HC Wainwright decreased their Q3 2027 earnings estimates for shares of HIVE Blockchain Technologies in a research note issued on Wednesday, November 11th. HC Wainwright analyst M. Colonnese now forecasts that the company will post earnings per share of ($0.21) for the quarter, down from their prior forecast of ($0.13). HC Wainwright also issued estimates for HIVE Blockchain Technologies’ Q4 2027 earnings at ($0.16) EPS, Q1 2028 earnings at ($0.13) EPS, Q2 2028 earnings at ($0.11) EPS, Q3 2028 earnings at ($0.10) EPS, Q4 2028 earnings at ($0.11) EPS and FY2028 earnings at ($0.47) EPS.
Separately, Chardan Capital upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a report on Monday, July 27th. Two investment analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Buy”.
HIVE Blockchain Technologies Stock Performance
HIVE Blockchain Technologies Ltd. is a technology company in the Application Software industry.
Recommended Stories
- Five stocks we like better than HIVE Blockchain Technologies
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
- Is It Too Late to Buy the Dip? 3 Corners of the Market Still Offering Real Value
- Why Equinix and Digital Realty Benefit From Data Center Zoning Battles
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
